Modified COVID-19 vaccines targeting variants can skip lengthy trials, UK says
March 05 2021, 08:00
Britain’s regulator on Thursday said modified coronavirus vaccines meant to target highly transmissible variants can sidestep new approvals and extended clinical trials.
Britain’s regulator on Thursday said modified coronavirus vaccines meant to target highly transmissible variants can sidestep new approvals and extended clinical trials.
Source:
FOX News